Patents by Inventor Wilma L. Suarez-Pinzon

Wilma L. Suarez-Pinzon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150152158
    Abstract: Provided herein are methods and compositions to achieve a sustained delay in the progression of, or an amelioration of diabetes in a subject, or a delay in diabetes onset in a subject at risk for diabetes, comprising an abbreviated course of administration of a pharmaceutical composition comprising an exendin or an exendin agonist analog in an amount effective to induce ? cell regeneration.
    Type: Application
    Filed: February 10, 2015
    Publication date: June 4, 2015
    Inventors: Alex RABINOVITCH, Wilma L. SUAREZ-PINZON
  • Publication number: 20140206613
    Abstract: Provided herein are methods and compositions to achieve a sustained delay in the progression of, or an amelioration of diabetes in a subject, or a delay in diabetes onset in a subject at risk for diabetes, comprising an abbreviated course of administration of a pharmaceutical composition comprising an exendin or an exendin agonist analog in an amount effective to induce ? cell regeneration.
    Type: Application
    Filed: March 31, 2014
    Publication date: July 24, 2014
    Applicants: AMYLIN PHARMACEUTICALS, LLC, ELI LILLY AND COMPANY
    Inventors: Alex RABINOVITCH, Wilma L. SUAREZ-PINZON
  • Publication number: 20130023471
    Abstract: Provided herein are methods and compositions to achieve a sustained delay in the progression of, or an amelioration of diabetes in a subject, or a delay in diabetes onset in a subject at risk for diabetes, comprising an abbreviated course of administration of a pharmaceutical composition comprising an exendin or an exendin agonist analog in an amount effective to induce cell regeneration.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 24, 2013
    Applicants: AMYLIN PHARMACEUTICALS, LLC., ELI LILLY AND COMPANY
    Inventors: Alex Rabinovitch, Wilma L. Suarez-Pinzon
  • Patent number: 8299024
    Abstract: Provided herein are methods and compositions to achieve a sustained delay in the progression of, or an amelioration of diabetes in a subject, or a delay in diabetes onset in a subject at risk for diabetes, comprising an abbreviated course of administration of a pharmaceutical composition comprising an exendin or an exendin agonist analog in an amount effective to induce cell regeneration.
    Type: Grant
    Filed: May 14, 2007
    Date of Patent: October 30, 2012
    Assignees: Amylin Pharmaceuticals, LLC, Eli Lilly and Company
    Inventors: Alex Rabinovitch, Wilma L. Suarez-Pinzon
  • Publication number: 20090203597
    Abstract: Provided herein are methods and compositions to achieve a sustained delay in the progression of, or an amelioration of diabetes in a subject, or a delay in diabetes onset in a subject at risk for diabetes, comprising an abbreviated course of administration of a pharmaceutical composition comprising an exendin or an exendin agonist analog in an amount effective to induce cell regeneration.
    Type: Application
    Filed: May 14, 2007
    Publication date: August 13, 2009
    Applicant: Amylin Pharmaceuticals, Inc
    Inventors: Alex Rabinovitch, Wilma L. Suarez-Pinzon